BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31636095)

  • 1. CRISPR/Cas9-mediated genome editing in nonhuman primates.
    Kang Y; Chu C; Wang F; Niu Y
    Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31636095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the genome editing tool CRISPR/Cas9 in non-human primates.
    Luo X; Li M; Su B
    Dongwuxue Yanjiu; 2016 Jul; 37(4):214-9. PubMed ID: 27469252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models.
    Barazesh M; Mohammadi S; Bahrami Y; Mokarram P; Morowvat MH; Saidijam M; Karimipoor M; Kavousipour S; Vosoughi AR; Khanaki K
    Curr Gene Ther; 2021; 21(2):130-148. PubMed ID: 33319680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mosaicism in CRISPR/Cas9-mediated genome editing.
    Mehravar M; Shirazi A; Nazari M; Banan M
    Dev Biol; 2019 Jan; 445(2):156-162. PubMed ID: 30359560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No off-target mutations in functional genome regions of a CRISPR/Cas9-generated monkey model of muscular dystrophy.
    Wang S; Ren S; Bai R; Xiao P; Zhou Q; Zhou Y; Zhou Z; Niu Y; Ji W; Chen Y
    J Biol Chem; 2018 Jul; 293(30):11654-11658. PubMed ID: 29941452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection.
    Schmidt JK; Reynolds MR; Golos TG; Slukvin II
    Retrovirology; 2022 Aug; 19(1):17. PubMed ID: 35948929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing in nonhuman primates: approach to generating human disease models.
    Chen Y; Niu Y; Ji W
    J Intern Med; 2016 Sep; 280(3):246-51. PubMed ID: 27114283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of mutation rates, mosaicism and off target mutations when injecting Cas9 mRNA or protein for genome editing of bovine embryos.
    Hennig SL; Owen JR; Lin JC; Young AE; Ross PJ; Van Eenennaam AL; Murray JD
    Sci Rep; 2020 Dec; 10(1):22309. PubMed ID: 33339870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.
    Hou Y; Ureña-Bailén G; Mohammadian Gol T; Gratz PG; Gratz HP; Roig-Merino A; Antony JS; Lamsfus-Calle A; Daniel-Moreno A; Handgretinger R; Mezger M
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 gene editing technology: a precise and efficient tool for crop quality improvement.
    Guo Y; Zhao G; Gao X; Zhang L; Zhang Y; Cai X; Yuan X; Guo X
    Planta; 2023 Jul; 258(2):36. PubMed ID: 37395789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering.
    Wada N; Ueta R; Osakabe Y; Osakabe K
    BMC Plant Biol; 2020 May; 20(1):234. PubMed ID: 32450802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
    Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
    Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted genome editing in primate embryos.
    Guo X; Li XJ
    Cell Res; 2015 Jul; 25(7):767-8. PubMed ID: 26032266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient generation of Knock-in/Knock-out marmoset embryo via CRISPR/Cas9 gene editing.
    Kumita W; Sato K; Suzuki Y; Kurotaki Y; Harada T; Zhou Y; Kishi N; Sato K; Aiba A; Sakakibara Y; Feng G; Okano H; Sasaki E
    Sci Rep; 2019 Sep; 9(1):12719. PubMed ID: 31481684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
    Jiang C; Meng L; Yang B; Luo X
    Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene editing monkeys: Retrospect and outlook.
    Liang W; He J; Mao C; Yu C; Meng Q; Xue J; Wu X; Li S; Wang Y; Yi H
    Front Cell Dev Biol; 2022; 10():913996. PubMed ID: 36158194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
    Jacinto FV; Link W; Ferreira BI
    J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic engineering in nonhuman primates for human disease modeling.
    Sato K; Sasaki E
    J Hum Genet; 2018 Feb; 63(2):125-131. PubMed ID: 29203824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.